SOLV

Solventum (NYSE: SOLV) will release its first quarter fiscal 2026 financial results on Tuesday, May 5, 2026...

Published: Apr 14, 2026   |  Read Original Article ↗

Article Summary

HOLD
  • Solventum (NYSE: SOLV) will release its first quarter fiscal 2026 financial results on Tuesday, May 5, 2026 after the U.S. financial markets close, with management hosting a webcast to discuss results following the release.
  • The company's earnings release, earnings press release, presentation slides and supplemental financial disclosures will be available on the Solventum website.
  • Other forward-looking and material information may also be discussed during the webcast, with replay of webcast and presentation slides available.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts. See Plans
Growth Stock Metric Rating
SOLV Rating
43.0
SELL

Growth Stock Scoring Breakdown

METRIC VALUE WEIGHT ANALYSIS
Sales Growth TTM ? 1.1% 25% 20.0 ptsMinimal (1.1%) - Very weak
EPS Growth Next 5Y ? 8.0% 25% 20.0 ptsWeak (8.0%) - Low expectations
Target Price Upside ? 25.3% 20% 75.0 ptsSignificant Upside (25.3%) - Target: $86.45 vs Current: $69.02
Gross Margin % ? 56.6% 15% 80.0 ptsVery Healthy (56.6%) - High-quality margins
Drawdown from 52-Wk High ? -21.8% 15% 40.0 ptsMild Pullback (-21.8%) - Light entry opportunity
Disclaimer: This rating is for informational purposes only and is not financial advice. All data sourced from Finviz. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.

SOLV - Daily Chart

Loading chart data...
Powered by Finviz & ApexCharts

About SOLV

Healthcare Medical Instruments & Supplies 20,584 employees Eagan, MN, United States
  • Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
  • It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
  • The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers.
  • The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs.
  • The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms.
  • The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce.
  • Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Get BUY-rated growth stocks delivered after market close.